Germany | BCH-RA-DE-103118 | Risk Assessment generated by a regulatory process | Biosafety Clearing-House

Loading...
Risk Assessment generated by a regulatory process (RA)
  |  
BCH-RA-DE-103118-4   |   PDF   |   Print   |  
published: 20 Feb 2012 last updated: 31 Jul 2020
General Information
6786-01-0176 (adv. 42010.0176); Summary of the risk assessment of a deliberate release (field trial) of genetically modified potato (Solanum tuberosum, varieties Albatros and Desirée) VP60, PsbY-cyeI, 35SctxBSEK and 35S-nptII, issued by the German Competent Authority
EN
21 Nov 2005
Risk assessment details
  • Potato modified for the expression of synthetic VP60 for vaccine production against RHDV
    | Universität Rostock | Production of medical or pharmaceutical compounds (human or animal) (Vaccines), Resistance to antibiotics (Kanamycin)
  • Potato resistant to aminoglycoside antibiotics
    | Universität Rostock | Resistance to antibiotics (Kanamycin, Neomycin)
  • Potato producing vaccine against cholera
    | Universität Rostock | Production of medical or pharmaceutical compounds (human or animal) (Vaccines), Resistance to antibiotics (Kanamycin)
  • Potato synthesizing cyanophycin biopolymer
    | Universität Rostock | Resistance to antibiotics (Kanamycin, Neomycin), Use in industrial applications
Methodology and points to consider
The execution of this field trial is not expected to have a negative impact on human or animal health, or on the environment.
EN
EN
EN
Adverse effects on human or animal health or on the environment are not expected.
EN
EN
EN
One site in Germany, for details refer to the German LMO/GMO location register (https://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?)
EN
construct specific PCR-based method
EN
Records referencing this document Show in search
Record type Field Record(s)
Country's Decision or any other Communication Risk assessment 1